Extract notice to the Minister
Rybrevant SC (Cancer du poumon)
Common name / Subject : amivantamab
Name of the manufacturer : Janss. Inc
Form : Sol. Inj. S.C.
Dosage : 160 mg/ml (10 ml), 160 mg/ml (14 ml), 160 mg/ml (15 ml), 160 mg/ml (22 ml)
Name of the manufacturer : Janss. Inc
Form : Sol. Inj. S.C.
Dosage : 160 mg/ml (10 ml), 160 mg/ml (14 ml), 160 mg/ml (15 ml), 160 mg/ml (22 ml)
Indication : Traitement du cancer du poumon non à petites cellules (CPNPC)
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
À venir
Evaluation published on November 12, 2026
INESSSid: 30718
Recevable on April 27, 2026